Ordynka Investments

Ordynka Investments is a private investment firm and holding company based in Cyprus, primarily active in the life sciences sector through significant equity stakes in biotechnology companies. The firm is most notably recognized as a major long-term investor in Geron Corporation, a biopharmaceutical company focused on telomerase inhibition therapy. Ordynka is associated with the investment portfolio of Alexander Abramov, a prominent industrialist, and has provided critical financial support for the development of imetelstat (Rytelo). While the firm does not operate its own research laboratories or drug development programs, its strategic capital has been pivotal in advancing treatments for hematologic malignancies. The company's involvement in the healthcare sector is characterized by a focus on high-innovation oncology assets and late-stage clinical development.